Literature DB >> 4818163

Reversible encephalopathy possibly associated with bismuth subgallate ingestion.

R Burns, D W Thomas, V J Barron.   

Abstract

Four patients who had undergone abdominoperineal resection for carcinoma of the colon and who had been taking oral bismuth subgallate developed a stereotyped recurrent and reversible neurological syndrome. This was characterized by confusion, tremulousness, clumsiness, myoclonic jerks, and an inability to walk. All patients were extensively investigated and no cause could be found, but symptoms regressed when the intake of bismuth was stopped. Postmortem examination in one patient failed to show any appreciable abnormality apart from a loss of Purkinje cells in the cerebellum. In the other three patients amino-acid chromatography performed on urine showed the presence of an abnormal unidentified constituent. It is thought that these four patients developed an encephalopathy associated with their bismuth subgallate ingestion.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4818163      PMCID: PMC1633100          DOI: 10.1136/bmj.1.5901.220

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  Cerebral demyelination associated with disorders of the reticuloendothelial system.

Authors:  J B CAVANAGH; D GREENBAUM; A H MARSHALL; L J RUBINSTEIN
Journal:  Lancet       Date:  1959-10-10       Impact factor: 79.321

2.  "Limbic encephalitis" and its association with carcinoma.

Authors:  J A Corsellis; G J Goldberg; A R Norton
Journal:  Brain       Date:  1968-09       Impact factor: 13.501

  2 in total
  19 in total

1.  D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate.

Authors:  C U Nwokolo; R E Pounder
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

2.  Does Bismuth Subgallate Affect Smell and Stool Character? A Randomized Double-Blinded Placebo-Controlled Trial of Bismuth Subgallate on Loop Duodenal Switch Patients with Complaints of Smelly Stools and Diarrhea.

Authors:  Hinali Zaveri; Amit Surve; Daniel Cottam; Walter Medlin; Christina Richards; Austin Cottam; Samuel Cottam
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

3.  [Monoamine metabolites and cyclic nucleotides in the cerebrospinal fluid of patients with bismuth or mercury poisoning].

Authors:  H Cramer; B Renaud; M Billiard; J Mouret; R Hammers
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-12-14

4.  Neuropsychiatric symptoms following bismuth intoxication.

Authors:  M P Weller
Journal:  Postgrad Med J       Date:  1988-04       Impact factor: 2.401

5.  Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients.

Authors:  V Supino-Viterbo; C Sicard; M Risvegliato; G Rancurel; A Buge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-08       Impact factor: 10.154

Review 6.  Toxic substances and the nervous system: the role of clinical observation.

Authors:  P M Le Quesne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-01       Impact factor: 10.154

7.  Adverse effects of anti-ulcer drugs.

Authors:  D A Henry; M J Langman
Journal:  Drugs       Date:  1981-06       Impact factor: 9.546

8.  Glutathione and multidrug resistance protein transporter mediate a self-propelled disposal of bismuth in human cells.

Authors:  Yifan Hong; Yau-Tsz Lai; Godfrey Chi-Fung Chan; Hongzhe Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-03       Impact factor: 11.205

Review 9.  Drug-induced myoclonus: frequency, mechanisms and management.

Authors:  Félix Javier Jiménez-Jiménez; Inmaculada Puertas; María de Toledo-Heras
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

10.  Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer.

Authors:  G Vantrappen; P Rutgeerts; L Broeckaert; J Janssens
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.